Table 3 Radiation and surgical intervention according to primary tumor site
Site | Both (%) | Radiation only (%) | Surgery only (%) | Neither rad. nor surgery (%) | Total (%) |
|---|---|---|---|---|---|
Bone (SBP) | |||||
 Axial skeleton (c41) | 177 (21.3%) | 481 (57.88%) | 58 (6.98%) | 115 (13.84%) | 831 (49.14%) |
 Appendicular skeleton (c40) | 30 (20.55%) | 78 (53.42%) | 15 (10.27%) | 23 (15.75%) | 146 (8.63%) |
Extramedullary plasmacytoma(EMP) | |||||
 Upper airway tract [Sino-nasal mouth and pharynx (c00-14, c33-39)] | 86 (40.76%) | 77 (36.49%) | 30 (14.22%) | 18 (8.53%) | 211 (12.48%) |
 Lower airway tract (c32-39) | 5 (9.26%) | 19 (35.19%) | 9 (16.67%) | 21 (38.89%) | 54 (3.19%) |
 Gastrointestinal Tract (c15- 26) | 2 (4.08%) | 11 (22.45%) | 24 (48.98%) | 12 (24.49%) | 49 (2.9%) |
 Soft tissue and connective tissue (c49) | 10 (12.99%) | 33 (43.86%) | 10 (12.99%) | 24 (31.17%) | 77 (4.55%) |
 Central nervous system (c69-72) | 17 (34.69%) | 15 (30.61%) | 16 (32.65%) | 1 (2.04%) | 49 (3.19%) |
 Lymph nodes (c27) | 10 (40%) | 5 (20%) | 5 (20%) | 5 (20%) | 25 (1.48%) |
 Skin (c44) | 4 (20%) | 6 (30%) | 8 (40%) | 2 (10%) | 20 (1.18%) |
 All other sites (c48,50,53,56,67,68,73,74) | 7 (12.73%) | 14 (25.45%) | 20 (36.36%) | 14 (25.45%) | 55 (3.25%) |
Plasmacytoma Unspecified (P-unspecified) | 11 (6.67%) | 86(49.41%) | 2 (1.21%) | 75 (43.11%) | 174 (10.28%) |
Total | 359 (21.23%) | 825 (48.79%) | 197 (11.65%) | 310 (18.33%) | 1691 (100%) |